{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:13:21Z","timestamp":1794266001543,"version":"4.9.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC2151 - project ID 390873048"],"award-info":[{"award-number":["EXC2151 - project ID 390873048"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["409510"],"award-info":[{"award-number":["409510"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Experimental validation and functional optimization remain bottlenecks in AI-based protein design. We present a scalable workflow for developing AI-designed minibinders against cancer-associated surface proteins. Screening thousands of designs using mammalian cell-surface display identifies several high-affinity PD-L1 minibinders but far fewer for CD276 (B7-H3) and VTCN1 (B7-H4), highlighting substantial target dependence. Interface predicted template modeling (ipTM) scores generated by Chai-1 with ESM embeddings correlate with binding success and capture deleterious effects of interface mutations. Fluorophore-labeled AI-minibinders enable flow-cytometric staining comparable to conventional antibodies. However, when incorporated into chimeric antigen receptors (CAR), some show poor cell-surface trafficking and limited functionality. Redesign through a genetic algorithm-based diversification strategy that preserves the binding interface while changing non-binding surfaces experimentally reveals an isoelectric point (pI) window that improves CAR expression and enhances target-selective tumor cell killing. Our findings identify biochemical optimization beyond the binding interface as a critical requirement for translating AI-minibinders into functional applications.<\/jats:p>","DOI":"10.1038\/s41467-026-76760-5","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:43:54Z","timestamp":1787240634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-436X","authenticated-orcid":false,"given":"Bianca","family":"Broske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7574-565X","authenticated-orcid":false,"given":"Benjamin A.","family":"McEnroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5573-1131","authenticated-orcid":false,"given":"Sophie C.","family":"Frechen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0173-2026","authenticated-orcid":false,"given":"Tim N.","family":"Kempchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline I.","family":"Fandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1787-496X","authenticated-orcid":false,"given":"Elisabeth","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-2858","authenticated-orcid":false,"given":"Dominic","family":"Ferber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C. R.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kleinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Messmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Konopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4790-5507","authenticated-orcid":false,"given":"Alexander","family":"Hoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Blumenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-5858","authenticated-orcid":false,"given":"Jan M. P.","family":"T\u00f6dtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1585-4100","authenticated-orcid":false,"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-2453","authenticated-orcid":false,"given":"Heiko","family":"R\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5424-3217","authenticated-orcid":false,"given":"Alexander","family":"Semaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieta I.","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Markova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5612-4673","authenticated-orcid":false,"given":"Sebastian","family":"Kobold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-3253","authenticated-orcid":false,"given":"Tim","family":"Rollenske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-5002","authenticated-orcid":false,"given":"Matthias","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4742-9335","authenticated-orcid":false,"given":"Stephan","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0061-235X","authenticated-orcid":false,"given":"Tobias","family":"Bald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Schmid-Burgk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8781-5664","authenticated-orcid":false,"given":"Gregor","family":"Hagelueken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-8824","authenticated-orcid":false,"given":"Michael","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"76760_CR1","doi-asserted-by":"publisher","first-page":"100745","DOI":"10.1016\/j.jbc.2021.100745","volume":"296","author":"IA Wilson","year":"2021","unstructured":"Wilson, I. A. & Stanfield, R. L. 50 Years of structural immunology. J. Biol. Chem. 296, 100745 (2021).","journal-title":"J. Biol. Chem."},{"key":"76760_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"76760_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"76760_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.abj8754","volume":"373","author":"M Baek","year":"2021","unstructured":"Baek, M. et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science 373, 871\u2013876 (2021).","journal-title":"Science"},{"key":"76760_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl2528","volume":"384","author":"R Krishna","year":"2024","unstructured":"Krishna, R. et al. Generalized biomolecular modeling and design with RoseTTAFold All-Atom. Science 384, eadl2528 (2024).","journal-title":"Science"},{"key":"76760_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.ads0018","volume":"387","author":"T Hayes","year":"2025","unstructured":"Hayes, T. et al. Simulating 500 million years of evolution with a language model. Science 387, 850\u2013858 (2025).","journal-title":"Science"},{"key":"76760_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","volume":"620","author":"JL Watson","year":"2023","unstructured":"Watson, J. L. et al. De novo design of protein structure and function with RFdiffusion. Nature 620, 1089\u20131100 (2023).","journal-title":"Nature"},{"key":"76760_CR8","doi-asserted-by":"publisher","unstructured":"Zambaldi, V. et al. De novo design of high-affinity protein binders with AlphaProteo. Preprint at https:\/\/doi.org\/10.48550\/arXiv.2409.08022 (2024).","DOI":"10.48550\/arXiv.2409.08022"},{"key":"76760_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41586-025-09429-6","volume":"646","author":"M Pacesa","year":"2025","unstructured":"Pacesa, M. et al. One-shot design of functional protein binders with BindCraft. Nature 646, 483\u2013492 (2025).","journal-title":"Nature"},{"key":"76760_CR10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41586-023-06728-8","volume":"623","author":"JB Ingraham","year":"2023","unstructured":"Ingraham, J. B. et al. Illuminating protein space with a programmable generative model. Nature 623, 1070\u20131078 (2023).","journal-title":"Nature"},{"key":"76760_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1107\/S2059798323003595","volume":"79","author":"J Agirre","year":"2023","unstructured":"Agirre, J. et al. The CCP 4 suite: integrative software for macromolecular crystallography. Acta Crystallogr. D. Struct. Biol. 79, 449\u2013461 (2023).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"76760_CR12","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","volume":"25","author":"PJA Cock","year":"2009","unstructured":"Cock, P. J. A. et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics 25, 1422\u20131423 (2009).","journal-title":"Bioinformatics"},{"key":"76760_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.add2187","volume":"378","author":"J Dauparas","year":"2022","unstructured":"Dauparas, J. et al. Robust deep learning\u2013based protein sequence design using ProteinMPNN. Science 378, 49\u201356 (2022).","journal-title":"Science"},{"key":"76760_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38328-5","volume":"14","author":"NR Bennett","year":"2023","unstructured":"Bennett, N. R. et al. Improving de novo protein binder design with deep learning. Nat. Commun. 14, 2625 (2023).","journal-title":"Nat. Commun."},{"key":"76760_CR15","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1038\/emm.2017.35","volume":"49","author":"FY Frejd","year":"2017","unstructured":"Frejd, F. Y. & Kim, K.-T. Affibody molecules as engineered protein drugs. Exp. Mol. Med. 49, e306 (2017).","journal-title":"Exp. Mol. Med."},{"key":"76760_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/pro.70360","volume":"34","author":"A Ravichandran","year":"2025","unstructured":"Ravichandran, A. et al. Structure-guided engineering of protein stability through core hydrophobicity. Protein Sci. 34, e70360 (2025).","journal-title":"Protein Sci."},{"key":"76760_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41580-024-00718-y","volume":"25","author":"D Listov","year":"2024","unstructured":"Listov, D., Goverde, C. A., Correia, B. E. & Fleishman, S. J. Opportunities and challenges in design and optimization of protein function. Nat. Rev. Mol. Cell Biol. 25, 639\u2013653 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"76760_CR18","doi-asserted-by":"publisher","first-page":"18632","DOI":"10.1039\/D5SC05576H","volume":"16","author":"X Leng","year":"2025","unstructured":"Leng, X. et al. De novo designed 3-helix bundle peptides and proteins with controlled topology and stability. Chem. Sci. 16, 18632\u201318641 (2025).","journal-title":"Chem. Sci."},{"key":"76760_CR19","doi-asserted-by":"publisher","first-page":"D364","DOI":"10.1093\/nar\/gku1028","volume":"43","author":"WG Touw","year":"2015","unstructured":"Touw, W. G. et al. A series of PDB-related databanks for everyday needs. Nucleic Acids Res. 43, D364\u2013D368 (2015).","journal-title":"Nucleic Acids Res."},{"key":"76760_CR20","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/bip.360221211","volume":"22","author":"W Kabsch","year":"1983","unstructured":"Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577\u20132637 (1983).","journal-title":"Biopolymers"},{"key":"76760_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01751-9","volume":"22","author":"AA Getu","year":"2023","unstructured":"Getu, A. A. et al. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development. Mol. Cancer 22, 43 (2023).","journal-title":"Mol. Cancer"},{"key":"76760_CR22","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/2767-9764.CRC-23-0546","volume":"4","author":"CD Miller","year":"2024","unstructured":"Miller, C. D. et al. Pan-cancer interrogation of B7-H3 (CD276) as an actionable therapeutic target across human malignancies. Cancer Res Commun. 4, 1369\u20131379 (2024).","journal-title":"Cancer Res Commun."},{"key":"76760_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.36401\/JIPO-24-34","volume":"8","author":"M Phipps","year":"2025","unstructured":"Phipps, M. & Falchook, G. S. B7 homolog 4 (B7-H4)-directed agents in oncology clinical trials: a review. J. Immunother. Precis. Oncol. 8, 153\u2013160 (2025).","journal-title":"J. Immunother. Precis. Oncol."},{"key":"76760_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10555-025-10260-8","volume":"44","author":"JJ Adashek","year":"2025","unstructured":"Adashek, J. J., Moran, J. A., Le, D. T. & Kurzrock, R. Lessons learned from a decade of immune checkpoint inhibition: the good, the bad, and the ugly. Cancer Metastasis Rev. 44, 43 (2025).","journal-title":"Cancer Metastasis Rev."},{"key":"76760_CR25","doi-asserted-by":"publisher","unstructured":"Barnett, A. J. et al. Benchmarking generative AI protein models reveals differences between structural and sequence-based approaches. Genom. Proteomics Bioinform. qzag014, https:\/\/doi.org\/10.1093\/gpbjnl\/qzag014 (2026).","DOI":"10.1093\/gpbjnl\/qzag014"},{"key":"76760_CR26","doi-asserted-by":"publisher","unstructured":"Chai Discovery et al. Chai-1: Decoding the molecular interactions of life. Preprint at https:\/\/doi.org\/10.1101\/2024.10.10.615955 (2024).","DOI":"10.1101\/2024.10.10.615955"},{"key":"76760_CR27","doi-asserted-by":"publisher","unstructured":"Wohlwend, J. et al. Boltz-1: Democratizing Biomolecular Interaction Modeling. Preprint at https:\/\/doi.org\/10.1101\/2024.11.19.624167 (2024).","DOI":"10.1101\/2024.11.19.624167"},{"key":"76760_CR28","doi-asserted-by":"crossref","unstructured":"Kallenborn, F. et al. GPU-accelerated homology search with MMseqs2. Nat. Methods. 22, 2024\u20132027 (2025).","DOI":"10.1038\/s41592-025-02819-8"},{"key":"76760_CR29","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.ade2574","volume":"379","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science 379, 1123\u20131130 (2023).","journal-title":"Science"},{"key":"76760_CR30","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41551-024-01258-8","volume":"8","author":"Z Xia","year":"2024","unstructured":"Xia, Z. et al. Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders. Nat. Biomed. Eng. 8, 1634\u20131650 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"76760_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/518027a","volume":"518","author":"A Bradbury","year":"2015","unstructured":"Bradbury, A. & Pl\u00fcckthun, A. Reproducibility: standardize antibodies used in research. Nature 518, 27\u201329 (2015).","journal-title":"Nature"},{"key":"76760_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.91645.2","volume":"12","author":"R Ayoubi","year":"2023","unstructured":"Ayoubi, R. et al. Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications. eLife 12, RP91645 (2023).","journal-title":"eLife"},{"key":"76760_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/d41586-024-03590-0","volume":"635","author":"D Kwon","year":"2024","unstructured":"Kwon, D. The antibodies don\u2019t work! The race to rid labs of molecules that ruin experiments. Nature 635, 26\u201328 (2024).","journal-title":"Nature"},{"key":"76760_CR34","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1182\/blood-2014-01-545020","volume":"124","author":"B Philip","year":"2014","unstructured":"Philip, B. et al. A highly compact epitope-based marker\/suicide gene for easier and safer T-cell therapy. Blood 124, 1277\u20131287 (2014).","journal-title":"Blood"},{"key":"76760_CR35","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1158\/1078-0432.CCR-18-2559","volume":"25","author":"E Drent","year":"2019","unstructured":"Drent, E. et al. Combined CD28 and 4-1BB costimulation potentiates affinity-tuned chimeric antigen receptor-engineered T cells. Clin. Cancer Res. 25, 4014\u20134025 (2019).","journal-title":"Clin. Cancer Res."},{"key":"76760_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","volume":"28","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z. et al. Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells. Cancer Cell 28, 415\u2013428 (2015).","journal-title":"Cancer Cell"},{"key":"76760_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41631-w","volume":"14","author":"D Li","year":"2023","unstructured":"Li, D. et al. Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours. Nat. Commun. 14, 5920 (2023).","journal-title":"Nat. Commun."},{"key":"76760_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","volume":"605","author":"L Cao","year":"2022","unstructured":"Cao, L. et al. Design of protein-binding proteins from the target structure alone. Nature 605, 551\u2013560 (2022).","journal-title":"Nature"},{"key":"76760_CR39","doi-asserted-by":"publisher","unstructured":"Tan, E. et al. Evolutionary algorithms accelerate de novo design of potent Nectin-4-specific cancer biologics. Preprint at https:\/\/doi.org\/10.64898\/2026.03.04.709551 (2026).","DOI":"10.64898\/2026.03.04.709551"},{"key":"76760_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cell.2020.06.007","volume":"182","author":"E Verschueren","year":"2020","unstructured":"Verschueren, E. et al. The immunoglobulin superfamily receptome defines cancer-relevant networks associated with clinical outcome. Cell 182, 329\u2013344.e19 (2020).","journal-title":"Cell"},{"key":"76760_CR41","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cell.2020.07.025","volume":"182","author":"WM Wojtowicz","year":"2020","unstructured":"Wojtowicz, W. M. et al. A human IgSF cell-surface interactome reveals a complex network of protein-protein interactions. Cell 182, 1027\u20131043.e17 (2020).","journal-title":"Cell"},{"key":"76760_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12860-019-0221-4","volume":"20","author":"A Kurotani","year":"2019","unstructured":"Kurotani, A. et al. Localization-specific distributions of protein pI in human proteome are governed by local pH and membrane charge. BMC Mol. Cell Biol. 20, 36 (2019).","journal-title":"BMC Mol. Cell Biol."},{"key":"76760_CR43","doi-asserted-by":"publisher","unstructured":"Chow, A. et al. Sequence and structural determinants of efficacious de novo chimeric antigen receptors. Preprint at https:\/\/doi.org\/10.64898\/2025.12.12.694033 (2025).","DOI":"10.64898\/2025.12.12.694033"},{"key":"76760_CR44","doi-asserted-by":"publisher","unstructured":"Kosonocky, C. W. et al. Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to Binders competition. Preprint at https:\/\/doi.org\/10.64898\/2026.03.03.709355 (2026).","DOI":"10.64898\/2026.03.03.709355"},{"key":"76760_CR45","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.omto.2020.04.001","volume":"17","author":"JA Hammill","year":"2020","unstructured":"Hammill, J. A. et al. A cross-reactive small protein binding domain provides a model to study off-tumor CAR-T cell toxicity. Mol. Ther. Oncol. 17, 278\u2013292 (2020).","journal-title":"Mol. Ther. Oncol."},{"key":"76760_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccell.2017.03.005","volume":"31","author":"S Seaman","year":"2017","unstructured":"Seaman, S. et al. Eradication of tumors through simultaneous ablation of CD276\/B7-H3-positive tumor cells and tumor vasculature. Cancer Cell 31, 501\u2013515.e8 (2017).","journal-title":"Cancer Cell"},{"key":"76760_CR47","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.1158\/1078-0432.CCR-19-1479","volume":"25","author":"A Balakrishnan","year":"2019","unstructured":"Balakrishnan, A. et al. Multispecific targeting with synthetic ankyrin repeat motif chimeric antigen receptors. Clin. Cancer Res. 25, 7506\u20137516 (2019).","journal-title":"Clin. Cancer Res."},{"key":"76760_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00755-5","volume":"13","author":"S Guo","year":"2025","unstructured":"Guo, S. & Xi, X. Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs. Biomark. Res. 13, 41 (2025).","journal-title":"Biomark. Res."},{"key":"76760_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa2303379","volume":"389","author":"J San-Miguel","year":"2023","unstructured":"San-Miguel, J. et al. Cilta-cel or standard care in lenalidomide-refractory multiple myeloma. N. Engl. J. Med. 389, 335\u2013347 (2023).","journal-title":"N. Engl. J. Med."},{"key":"76760_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pep.2008.09.008","volume":"63","author":"H Liu","year":"2009","unstructured":"Liu, H. & Naismith, J. H. A simple and efficient expression and purification system using two newly constructed vectors. Protein Expr. Purif. 63, 102\u2013111 (2009).","journal-title":"Protein Expr. Purif."},{"key":"76760_CR51","doi-asserted-by":"publisher","first-page":"101128","DOI":"10.1016\/j.xpro.2022.101128","volume":"3","author":"H Kanemaru","year":"2022","unstructured":"Kanemaru, H., Mizukami, Y., Kaneko, A., Kajihara, I. & Fukushima, S. A protocol for quantifying lymphocyte-mediated cytotoxicity using an impedance-based real-time cell analyzer. STAR Protoc. 3, 101128 (2022).","journal-title":"STAR Protoc."},{"key":"76760_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-0716-4188-0_5","volume":"2865","author":"T Rollenske","year":"2025","unstructured":"Rollenske, T., Murugan, R., Wardemann, H. & Busse, C. E. Expression cloning of antibodies from single human B cells. Methods Mol. Biol. 2865, 103\u2013124 (2025).","journal-title":"Methods Mol. Biol."},{"key":"76760_CR53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76760-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76760-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76760-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:56:57Z","timestamp":1787241417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76760-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76760"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76760-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.H. reports travel expenses, honoraria for webinars and research support (consumables) from TME Pharma AG unrelated to this work. M.H. also reports honoraria and clinical advisory board membership from OncoMAGNETx Inc unrelated to this work. M.H.\u2014listed as an inventor\u2014reports a PCT filing (RH02A02\/P-WO, pending) by the University of Bonn, Germany, for a CAM-assay-based testing platform for biologics and cellular therapies unrelated to the mammalian cell-surface display. A.H. and J.L.S.-B. are inventors on a patent application (pending) related to pooled screening of AI-minibinders, which was filed by the University Bonn (DE10 2025 118 201.9), but unrelated to the mammalian cell-surface display and phage display described in this work. J.L.S.-B. is a co-founder and shareholder of ions.bio GmbH and LAMPseq Diagnostics GmbH. S.K. has received honoraria from Plectonic, TCR2 Inc., Miltenyi, Galapagos, Cymab, Novartis, BMS and GSK. S.K. is an inventor of several patents in the field of immuno-oncology. S.K. received license fees from TCR2 Inc and Carina Biotech. S.K. received research support from TCR2 Inc., Tabby Therapeutics, Catalym GmbH, Plectonic GmbH and Arcus Bioscience for work unrelated to the manuscript. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8736"}}